Nagoya City University

This trial is testing whether combining two existing drugs—ribociclib and anastrozole—works better together for people with advanced or returning breast cancer. The study will involve 86 Japanese patients whose cancer is hormone-sensitive but HER2-negative. Researchers will first…

This study is testing if a drug called abemaciclib can prevent breast cancer from returning in people who have already had surgery and standard treatment. Researchers will use a special blood test to detect tiny traces of cancer early, and if found, participants will take the dru…